|
second-line systemic therapy Clinical Trials
1 actively recruiting trial
Also known as: albumin-bound paclitaxel-based chemotherapy, docetaxel-based chemotherapy, immunotherapy
Pipeline
Phase 3: 1
Top Sponsors
- Second Affiliated Hospital, School of Medicine, Zhejiang University1
Indications
- OligoProgressive Metastatic Disease1
- Metastatic Non-Small Cell Lung Cancer1
- NSCLC Stage IV1
- Lung Cancer1
- Cancer1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.